A double-blind placebo-controlled trial of Rozerem [ramelteon] in migraine headaches.

Trial Profile

A double-blind placebo-controlled trial of Rozerem [ramelteon] in migraine headaches.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 09 Feb 2012

At a glance

  • Drugs Ramelteon (Primary)
  • Indications Migraine
  • Focus Therapeutic Use
  • Most Recent Events

    • 09 Feb 2012 Last checked against ClinicalTrials.gov record.
    • 09 Feb 2012 Actual patient number is 4 according to ClinicalTrials.gov.
    • 09 Feb 2012 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top